Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function

NCT00949663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Placebo
DRUG: Glucose-dependent Insulinotropic Polypeptide (GIP)
DRUG: Xenin-25
DRUG: Glucose-dependent Insulinotropic Polypeptide plus Xenin-25

Sponsor

Washington University School of Medicine

Collaborators

[object Object]